These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 28244992)

  • 1. Overcoming cellular barriers for RNA therapeutics.
    Dowdy SF
    Nat Biotechnol; 2017 Mar; 35(3):222-229. PubMed ID: 28244992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives, issues and solutions in RNAi therapy: the expected and the less expected.
    Aigner A
    Nanomedicine (Lond); 2019 Nov; 14(21):2777-2782. PubMed ID: 31752594
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
    Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
    Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in siRNA delivery.
    Sarisozen C; Salzano G; Torchilin VP
    Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-targeted therapeutics in cancer clinical trials: Current status and future directions.
    Barata P; Sood AK; Hong DS
    Cancer Treat Rev; 2016 Nov; 50():35-47. PubMed ID: 27612280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-Based Nanocarriers for RNA Delivery.
    Xue HY; Guo P; Wen WC; Wong HL
    Curr Pharm Des; 2015; 21(22):3140-7. PubMed ID: 26027572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of siRNA Nanosheets for Efficient RNA Interference.
    Kim H; Lee JS; Lee JB
    Sci Rep; 2016 Apr; 6():25146. PubMed ID: 27120975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct cytoplasmic delivery of RNAi therapeutics through a non-lysosomal pathway for enhanced gene therapy.
    Zhou J; Zhang J; Chen S; Lin Q; Zhu R; Wang L; Chen X; Li J; Yang H
    Acta Biomater; 2023 Oct; 170():401-414. PubMed ID: 37625679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of RNA Therapeutics: The Great Endosomal Escape!
    Dowdy SF; Setten RL; Cui XS; Jadhav SG
    Nucleic Acid Ther; 2022 Oct; 32(5):361-368. PubMed ID: 35612432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Growing Class of Novel RNAi Therapeutics.
    Traber GM; Yu AM
    Mol Pharmacol; 2024 Jun; 106(1):13-20. PubMed ID: 38719476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current issues of RNAi therapeutics delivery and development.
    Haussecker D
    J Control Release; 2014 Dec; 195():49-54. PubMed ID: 25111131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial focus: understanding off-target effects as the key to successful RNAi therapy.
    Bartoszewski R; Sikorski AF
    Cell Mol Biol Lett; 2019; 24():69. PubMed ID: 31867046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Interfering RNAs and RNA Therapeutics in Cardiovascular Diseases.
    Bansal P; Arora M
    Adv Exp Med Biol; 2020; 1229():369-381. PubMed ID: 32285425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases.
    Pandey M; Ojha D; Bansal S; Rode AB; Chawla G
    Mol Aspects Med; 2021 Oct; 81():101003. PubMed ID: 34332771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of RNA interference-based therapeutics and application of multi-target small interfering RNAs.
    Li T; Wu M; Zhu YY; Chen J; Chen L
    Nucleic Acid Ther; 2014 Aug; 24(4):302-12. PubMed ID: 24796432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA therapeutics: RNAi and antisense mechanisms and clinical applications.
    Chery J
    Postdoc J; 2016 Jul; 4(7):35-50. PubMed ID: 27570789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?
    Dowdy SF
    RNA; 2023 Apr; 29(4):396-401. PubMed ID: 36669888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
    Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK
    Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Oligonucleotide Therapeutics in Oncology.
    Xiong H; Veedu RN; Diermeier SD
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.